Topical 15% Lactic Acid Solution Versus Topical Betamethasone Valerate Lotion in Treatment of Multiple Patchy Alopecia Areata

January 2024 in “ Al-Azhar International Medical Journal /Al-Azhar International Medical Journal ”

Ramy Taher Mohamed Aboelghait, Amr Mohamed Zaki, Emad Mahmoud El Rewiny

lactic acid betamethasone valerate alopecia areata topical treatment betamethasone

From the encyclopedia

Lactic Acid →

Betamethasone Valerate →

Alopecia Areata →

autoimmune disorder causing patchy hair loss

Studysummary This study concluded that topical betamethasone valerate lotion is more effective than 15% lactic acid solution for managing multiple patchy alopecia areata over a 12-week period in a sample of 50 patients. Our plain-language summary of this paper — not a Tressless recommendation.

The study compared the efficacy of topical 15% lactic acid solution and topical betamethasone valerate lotion in treating multiple patchy alopecia areata. Fifty patients were divided into two groups of 25 each, with one group using lactic acid and the other using betamethasone valerate for 12 weeks. The results indicated that betamethasone valerate lotion was more effective in managing multiple patchy alopecia areata. The study suggests that future research with larger sample sizes, longer follow-up periods, and side effect evaluations could provide more comprehensive insights.

View this study on aimj.researchcommons.org →

Discuss this study in the Community →

Research cited in this study

7 / 7 results

research Efficacy of Jessner Solution Versus Intralesional Steroid in Treatment of Alopecia Areata

4 citations , November 2022 in “Journal of Cosmetic Dermatology”

This study found that both intralesional steroid injections and Jessener solution were more effective than saline in treating alopecia areata, with no significant difference between the two active treatments.

research Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update

20 citations , March 2021 in “Drug design, development and therapy”

This review summarizes the pharmacology, mechanisms, and clinical efficacy of topical immunotherapy for alopecia areata but reports no new clinical results.

research Intralesional Triamcinolone Acetonide Versus Topical Betamethasone Valerate in the Management of Localized Alopecia Areata

18 citations , December 2015 in “PubMed”

This study found that intralesional triamcinolone was more effective than topical betamethasone for hair regrowth in patients with localized alopecia areata.

research Alopecia Areata: An Evidence-Based Treatment Update

72 citations , July 2014 in “American journal of clinical dermatology”

This review analyzed randomized controlled trials on alopecia areata treatment and found that while several treatments showed effectiveness, most studies had limitations affecting their interpretability.

research Interventions for Alopecia Areata

2 citations , February 2009 in “Journal of Evidence-Based Medicine”

This review of randomized controlled trials for alopecia areata treatments found that none were significantly better than placebo in promoting long-term hair growth, with most trials being small and poorly reported.

research Comparison of Effectiveness of Topical Tacrolimus and Betamethasone with Soft Paraffin in the Treatment of Patchy Alopecia Areata

5 citations , January 2009

This study found that Betamethasone was more effective than Tacrolimus and soft paraffin in promoting hair regrowth in patients with mild to moderate patchy alopecia areata.

research Alopecia Areata Update

49 citations , April 2000 in “Journal of The American Academy of Dermatology”

This article discusses the etiology, clinical features, diagnosis, histopathology, and treatment of alopecia areata but reports no new clinical findings; it emphasizes the palliative nature of current treatments.